title: Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis.
authors.affiliation: Department of Clinical Pharmacology, Sahlgrenska University Hospital, Göteborg, Sweden. thomas.hedner@pharm.gu.se
authors.forename: Thomas
authors.initials: T
authors.lastname: Hedner
authors.forename: Ola
authors.initials: O
authors.lastname: Samulesson
authors.forename: Peter
authors.initials: P
authors.lastname: Währborg
authors.forename: Hans
authors.initials: H
authors.lastname: Wadenvik
authors.forename: Kjell-Arne
authors.initials: KA
authors.lastname: Ung
authors.forename: Anders
authors.initials: A
authors.lastname: Ekbom
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000378:metabolism / Q000493:pharmacokinetics / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002074:Butanones / Q000378:metabolism / Q000493:pharmacokinetics / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D004347:Drug Interactions; D018565:Food-Drug Interactions; D006801:Humans; D008875:Middle Aged; D000077430:Nabumetone; D010003:Osteoarthritis / Q000188:drug therapy*; D013272:Stomach Diseases / Q000139:chemically induced*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D002074:Butanones; D016861:Cyclooxygenase Inhibitors; D000077430:Nabumetone